Olivia Ware is the Senior Vice President of US Market and Franchise Development for Proteus Digital Health. Proteus is an innovative company utilizing technology to enable a new category of pharmaceuticals: Digital Medicines.
Reporting to the CEO and a member of the Executive team, Olivia leads the commercial organization at Proteus. In this role, she is responsible for the company’s commercial strategy, focusing on growth strategies to expand the use of digital medicines.
The teams in her group include marketing; account management; corporate communications and public relations; public policy and government affairs as well as implementation teams working directly with customers at provider and health system sites.
Olivia is a successful executive with over 20 years of experience in commercialization, pharmaceutical drug development and healthcare management.
In her prior role at Genentech Inc., Olivia played a key role in the launch of several of the world’s largest revenue-producing oncology drugs, including Rituxan®, Herceptin® and Avastin®.
Olivia has an MBA in Finance and Marketing from the University of North Carolina at Chapel Hill and an A.B. from Davidson College.
